CIHR-ICRH/CSATVB Mid-Career Excellence Award in Blood and Blood Vessel Research

Faculty of Medicine
Department of Biochemistry, Microbiology and Immunology
Awards and recognition
award trophies kept on a table
Dr. Katey Rayner – Recipient of the 2023 CIHR-ICRH/CSATVB Mid-Career Excellence Award in Blood and Blood Vessel Research.

The CIHR-ICRH and the Canadian Society of Atherosclerosis, Thrombosis and Vascular Biology (CSATVB) have partnered on the Mid-Career Excellence Award in Blood and Blood Vessel Research to recognize an individual's outstanding contribution to the advancement of blood and/or blood vessel sciences both in Canada and internationally at the mid-point of their career. The award will be presented to the selected candidate at the Canadian Lipid and Vascular Summit, where the recipient will deliver a lecture as part of the scientific program. The Canadian Lipid and Vascular Summit is a joint scientific symposium of the CSATVB and the Canadian Lipoprotein Conference.

Katey Rayner is a Professor in the Department of Biochemistry, Microbiology & Immunology at the University of Ottawa, where she runs a research lab at the University of Ottawa Heart Institute. She is also the Assistant Dean of Research in the Faculty of Medicine in Ottawa, Canada. Dr. Rayner’s research program focuses how inflammation underlies common diseases like coronary artery disease, obesity and dementia. Her lab is trying to understand the molecular signals that cause inappropriate activation of the immune system and how we can use this understanding to either better diagnose/identify patients at risk of disease, or to better treat this excess inflammation directly to lower risk of disease.

Dr. Rayner has been recognized with awards such as the Joseph A Vita Award (American Heart Association), Canadian Society for Molecular Biosciences Young Investigator Award, and is a member of the College of New Scholars of the Royal Society of Canada. Dr. Rayner’s research is currently funded by the Canadian Institutes for Health Research, the Heart and Stroke Foundation of Canada and the European Cardiovascular Research Network.